These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37731082)

  • 1. Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
    Nakayama M; Furuya T; Inoue E; Tanaka E; Ikari K; Yamanaka H; Harigai M
    Clin Rheumatol; 2024 Jan; 43(1):521-526. PubMed ID: 37731082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study.
    Furuya T; Oh K; Ikari K; Inoue E; Tanaka E; Yamanaka H; Harigai M
    Clin Rheumatol; 2022 Feb; 41(2):405-410. PubMed ID: 34586516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.
    Ben Tekaya A; Mehmli T; Ben Sassi M; Teyeb Z; Bouden S; Rouached L; Mahmoud I; Dziri C; Abdelmoula L
    Clin Rheumatol; 2023 Apr; 42(4):979-997. PubMed ID: 36462127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis.
    Torii M; Hashimoto M; Hanai A; Fujii T; Furu M; Ito H; Uozumi R; Hamaguchi M; Terao C; Yamamoto W; Uda M; Nin K; Morita S; Arai H; Mimori T
    Mod Rheumatol; 2019 Jul; 29(4):589-595. PubMed ID: 30092163
    [No Abstract]   [Full Text] [Related]  

  • 5. Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture.
    Ochi K; Inoue E; Furuya T; Ikari K; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    Osteoporos Int; 2015 Mar; 26(3):961-8. PubMed ID: 25294026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study.
    Mochizuki T; Yano K; Ikari K; Okazaki K
    Geriatr Gerontol Int; 2019 Sep; 19(9):907-912. PubMed ID: 31342647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does age bias the aggressive treatment of elderly patients with rheumatoid arthritis?
    Harrison MJ; Kim CA; Silverberg M; Paget SA
    J Rheumatol; 2005 Jul; 32(7):1243-8. PubMed ID: 15996058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.
    Markenson JA; Koenig AS; Feng JY; Chaudhari S; Zack DJ; Collier D; Weaver A
    J Clin Rheumatol; 2013 Sep; 19(6):317-23. PubMed ID: 23965479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis.
    Hasegawa E; Ito S; Kurosawa Y; Kobayashi D; Otani H; Abe A; Nakazono K; Murasawa A; Narita I; Ishikawa H
    Intern Med; 2023; 62(3):373-379. PubMed ID: 36725065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.
    Shidara K; Hoshi D; Inoue E; Yamada T; Nakajima A; Taniguchi A; Hara M; Momohara S; Kamatani N; Yamanaka H
    Mod Rheumatol; 2010 Jun; 20(3):280-6. PubMed ID: 20217173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Dao T; Kirk B; Phu S; Vogrin S; Duque G
    Calcif Tissue Int; 2021 Nov; 109(5):475-489. PubMed ID: 34132852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry.
    Karataş A; Pişkin Sağir R; Koca SS; Dalkiliç E; Can G; Pehlivan Y; Yazici A; Inanç N; Cefle A; Ertürk Z; Akar S; Şenel S; Birlik M; Akkoç N; Önen F
    Turk J Med Sci; 2023; 53(5):1321-1329. PubMed ID: 38813042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.
    Tanaka E; Inoue E; Yamaguchi R; Shimizu Y; Kobayashi A; Sugimoto N; Hoshi D; Shidara K; Sato E; Seto Y; Nakajima A; Momohara S; Taniguchi A; Yamanaka H
    Mod Rheumatol; 2017 Mar; 27(2):227-236. PubMed ID: 27472516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease-modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data.
    Higuchi T; Tanaka E; Inoue E; Abe M; Saka K; Sugano E; Sugitani N; Higuchi Y; Ochiai M; Yamaguchi R; Ikari K; Yamanaka H; Harigai M
    Mod Rheumatol; 2024 Jul; 34(4):693-699. PubMed ID: 37409749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
    Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H
    BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study.
    Ingrasciotta Y; Jin Y; Foti SS; Landon JE; Tari M; Mattace-Raso F; Kim SC; Trifirò G
    Clin Rheumatol; 2023 Apr; 42(4):1047-1059. PubMed ID: 36534353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study.
    Tarannum S; Widdifield J; Wu CF; Johnson SR; Rochon P; Eder L
    J Rheumatol; 2024 Jul; 51(7):703-707. PubMed ID: 38692668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for total knee arthroplasty in rheumatoid arthritis.
    Momohara S; Inoue E; Ikari K; Kawamura K; Tsukahara S; Mochizuki T; Toki H; Miyawaki M; Saito S; Hara M; Kamatani N; Yamanaka H; Tomatsu T
    Mod Rheumatol; 2007; 17(6):476-80. PubMed ID: 18084699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib.
    Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A; Reyes JM; Gamboa NC
    Clin Rheumatol; 2021 Apr; 40(4):1273-1281. PubMed ID: 32997316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer.
    Pundole X; Zamora NV; Siddhanamatha H; Lin H; Tayar J; Hong LC; Li L; Suarez-Almazor ME
    Clin Rheumatol; 2020 Mar; 39(3):787-794. PubMed ID: 31853733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.